British drugmaker AstraZeneca is set to release 25 new products in Egypt in three years, said Hatem Werdany on Wednesday at Africa Health ExCon 2023. Werdany also said that the conference is a "fertile ground" for new foreign pharmaceutical investments. According to Werdany, AstraZeneca also launched a programme under the title Accelerating Change Together: Cancer Care in Africa (ACT; CCA) in November 2022 that aims to create more effective cancer care solutions. Werdany also said that the health sector in Egypt had witnessed a huge "boom" over the last few years, which reflects the country's ability to become a regional hub for healthcare.